275 Patient perspectives on GLP-1 receptor agonists for weight loss: A mixed-methods study to inform translational obesity care
Jane McElroy, Regina DePietro, Chloe Zink, Isabella Bertarelli, Jamie Smith · 2026
Read 275 Patient perspectives on GLP-1 receptor agonists for weight loss: A mixed-methods study to inform translational obesity care by Jane McElroy, Regina DePietro, Chloe Zink, Isabella Bertarelli, Jamie Smith (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13172905.txt.
Description
Jane McElroy and co-authors ask patients how they feel about new drugs for weight loss. Their 2026 study covers adults with no diabetes who were thinking about, using, or had stopped a GLP-1 drug. From March to July 2025, 140 people filled in a survey and took part in a long interview. Groups were split by stage of use.
Some users said food held less pull, and that meals changed. Others who lost weight feared losing access due to cost or cover, and then gaining it back. Some stopped due to side effects or cost. Women often faced stigma, with claims that drug aided loss was cheating. Men rarely reported such comments. Less food noise was a common gain.
Catalog record
| CREATOR | Jane McElroy, Regina DePietro, Chloe Zink, Isabella Bertarelli, Jamie Smith |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |